Correlation Between Apellis Pharmaceuticals and MedinCell

Can any of the company-specific risk be diversified away by investing in both Apellis Pharmaceuticals and MedinCell at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apellis Pharmaceuticals and MedinCell into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Apellis Pharmaceuticals and MedinCell SA, you can compare the effects of market volatilities on Apellis Pharmaceuticals and MedinCell and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apellis Pharmaceuticals with a short position of MedinCell. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apellis Pharmaceuticals and MedinCell.

Diversification Opportunities for Apellis Pharmaceuticals and MedinCell

0.0

Correlation Coefficient

Apellis Pharmaceuticals  MedinCell

Pay attention - limited upside

The 3 months correlation between Apellis and MedinCell is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Apellis Pharmaceuticals and MedinCell SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MedinCell SA and Apellis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apellis Pharmaceuticals are associated (or correlated) with MedinCell. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MedinCell SA has no effect on the direction of Apellis Pharmaceuticals i.e., Apellis Pharmaceuticals and MedinCell go up and down completely randomly.

Pair Corralation between Apellis Pharmaceuticals and MedinCell

If you would invest  2,738  in Apellis Pharmaceuticals on October 14, 2024 and sell it today you would earn a total of  6.00  from holding Apellis Pharmaceuticals or generate 0.22% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	98.41%
Values	Daily Returns

Apellis Pharmaceuticals  vs.  MedinCell SA

Apellis Pharmaceuticals

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Apellis Pharmaceuticals are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable essential indicators, Apellis Pharmaceuticals is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

MedinCell SA

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days MedinCell SA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable essential indicators, MedinCell is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with Apellis Pharmaceuticals and MedinCell

The main advantage of trading using opposite Apellis Pharmaceuticals and MedinCell positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apellis Pharmaceuticals position performs unexpectedly, MedinCell can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MedinCell will offset losses from the drop in MedinCell's long position.

The idea behind Apellis Pharmaceuticals and MedinCell SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.